KGET Share Price Performance
US$0.000001
0.00 (0.00%)
Price US$0.000001
Share PriceUS$0.000001
KGET Community Narratives
There are no narratives available yet.
Recent KGET News & Updates
No updates
CaliPharms, Inc. Key Details
Last Reported Earnings
Sep 30, 2014
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
CaliPharms, Inc. Competitors
About KGET
- Founded
- n/a
- Employees
- n/a
- CEO
- Website
CaliPharms, Inc. engages in the medicinal Cannabis Industry in the United States. It focuses on the THC and CBD beverage industry. The company was formerly known as Kleangas Energy Technologies, Inc. and changed its name to CaliPharms, Inc. in January, 2017. CaliPharms, Inc. is based in Temecula, California.
U.S. Market Performance
- 7 Days: -0.2%
- 3 Months: 12.2%
- 1 Year: 22.4%
- Year to Date: 7.7%
Over the last 7 days, the market has remained flat, although notably the Communication Services sector gained 3.4% in that time. As for the longer term, the market has risen 22% in the past 12 months. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading